India's cancer crisis is not defined by a lack of science. The drugs, treatments and expertise exist. And yet, patients are dying—because the system refuses to let them access it. This stark reality, highlighted by B S Ajaikumar in a recent opinion piece, underscores the urgent need for policy reform in the country's healthcare framework.
The Gap Between Knowledge and Access
India boasts world-class oncologists, advanced radiation machines, and a robust pharmaceutical industry capable of producing affordable generic drugs. However, the benefits of these resources are not reaching the majority of patients. The primary barrier is not scientific or technological but systemic: weak policies, bureaucratic red tape, and fragmented healthcare delivery.
Policy Failures at Multiple Levels
Several factors contribute to this access gap. First, screening programs remain underfunded and poorly implemented, leading to late-stage diagnoses. Second, the lack of a comprehensive national cancer registry hampers data-driven policymaking. Third, insurance coverage for cancer treatment is inadequate, pushing families into debt. Fourth, the shortage of trained oncology professionals in rural areas exacerbates inequities.
Moreover, the regulatory environment for new treatments is slow and cumbersome, delaying patient access to innovative therapies. While the government has launched initiatives like the Ayushman Bharat scheme, coverage for cancer care is limited, and many patients fall through the cracks.
The Human Cost of Inaction
The consequences are devastating. Every year, over 1.1 million new cancer cases are diagnosed in India, and nearly 800,000 people die from the disease. Many of these deaths are preventable with early detection and timely treatment. The current system, however, forces patients to navigate a maze of referrals, long waiting times, and out-of-pocket expenses that often prove catastrophic.
B S Ajaikumar argues that the solution lies not in more research but in political will and administrative efficiency. Strengthening primary healthcare, integrating cancer care into existing health systems, and leveraging technology for telemedicine and digital health records could transform outcomes.
Urgent Reforms Needed
To bridge the gap, policymakers must prioritize: expanding screening programs, especially for breast, cervical, and oral cancers; increasing funding for public cancer hospitals; streamlining drug approval processes; and ensuring universal health coverage that includes comprehensive cancer care. Additionally, public-private partnerships can help scale up infrastructure and training.
The cost of weak cancer policies is measured in lives lost. India has the tools to fight cancer—what it lacks is the resolve to deploy them effectively. Without immediate action, the crisis will only deepen.
